Page last updated: 2024-11-05

dipicrylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dipicrylamine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8576
SCHEMBL ID2218947
MeSH IDM0057772

Synonyms (64)

Synonym
AKOS003404771
2,4,4',6,6'-hexanitrodiphenylamine
diphenylamine,2',4,4',6,6'-hexanitro-
diphenylamine, hexanitro-
nsc1786
dipicrylamine
2,6-trinitro-n-(2,4,6-trinitrophenyl)benzenamine
esanitrodifenilamina
benzenamine,4,6-trinitro-n-(2,4,6-trinitrophenyl)-
hexyl (reagent)
wln: wnr cnw enw bmr bnw dnw fnw
hexamine (potassium reagent)
nsc-1786
hexanitrodifenylamine
bis(2,6-trinitro-phenyl)-amin
2,6,2',4',6'-hexanitrodiphenylamine
131-73-7
hexyl
bis(2,6-trinitrophenyl)amine
hexanitrodiphenylamine
bis(2,4,6-trinitro-phenyl)-amin [german]
2,2',4,4',6,6'-hexanitrodifenylamin [czech]
diphenylamine, 2,2',4,4',6,6'-hexanitro-
c.i. 10360
nsc 1786
benzenamine, 2,4,6-trinitro-n-(2,4,6-trinitrophenyl)-
dipikrylamin [czech]
brn 0735589
hexite
2,2,4,4,6,6-hexanitrodiphenylamine
hexyl [german, dutch]
2,4,6,2',4',6'-hexanitrodiphenylamine
hexyl (van)
esanitrodifenilamina [italian]
hexanitrodifenylamine [dutch]
einecs 205-037-8
hsdb 2873
2,4,6-trinitro-n-(2,4,6-trinitrophenyl)benzenamine
un0079
bis(2,4,6-trinitrophenyl)amine
2,2',4,4',6,6'-hexanitrodiphenylamine
ccris 5347
hexanitrodiphenylamine [french]
inchi=1/c12h5n7o12/c20-14(21)5-1-7(16(24)25)11(8(2-5)17(26)27)13-12-9(18(28)29)3-6(15(22)23)4-10(12)19(30)31/h1-4,13
2,4,6-trinitro-n-(2,4,6-trinitrophenyl)aniline
STK664288
ammonium 2,4,6-trinitrophenyl-n-(2,4,6-trinitrocyclohexa-2,5-dien-1-ylidene)amide
14str4kg8t ,
hexanitrodiphenylamine or dipicrylamine or hexyl
dipikrylamin
unii-14str4kg8t
4-12-00-01737 (beilstein handbook reference)
bis(2,4,6-trinitro-phenyl)-amin
hexanitrodiphenylamine or dipicrylamine or hexyl [un0079] [explosive 1.1d]
2,2',4,4',6,6'-hexanitrodifenylamin
FT-0631764
dipicrylamine [mi]
DTXSID4059621
SCHEMBL2218947
CBCIHIVRDWLAME-UHFFFAOYSA-N
2,4,6-trinitro-n-(2,4,6-trinitrophenyl)aniline #
SR-01000089828-1
sr-01000089828
Q414335

Research Excerpts

Overview

Dipicrylamine (DPA) is a commonly used acceptor agent in Förster resonance energy transfer experiments that allows the study of high-frequency neuronal activity.

ExcerptReferenceRelevance
"Dipicrylamine (DPA) is a commonly used acceptor agent in Förster resonance energy transfer experiments that allows the study of high-frequency neuronal activity in the optical monitoring of voltage in living cells. "( Dipicrylamine Modulates GABAρ1 Receptors through Interactions with Residues in the TM4 and Cys-Loop Domains.
Estrada-Mondragón, A; Limon, A; Miledi, R; Ruiz, JM, 2016
)
3.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (41.18)18.7374
1990's10 (19.61)18.2507
2000's6 (11.76)29.6817
2010's14 (27.45)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.85 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index79.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other52 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]